Dr. Notghi Contract Research

Name

Dr. Notghi Contract Research

Legal name

Dr. Notghi Contract Research GmbH

Website

https://notghi.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Contract Research Organization Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAAAA

Clinical CROs (Phase I–IV)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAH

Pharmacovigilance, Risk Management & Medical Affairs CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAL

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAG

Medical Writing & Regulatory Submission Support CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYEDAOAJAO

Clinical Research Support (CRC/CTA)

Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training

Keywords

• Clinical trial management
• Pharmacovigilance services
• Medical device evaluation
• Drug safety reporting
• GCP training services

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Services: Project and study management, clinical monitoring, data management, and medical writing services for pharmaceutical companies and medical device sponsors conducting interventional and non-interventional clinical studies. Services are delivered on a project/fee-for-service basis.
2. Pharmacovigilance Services: Individual case processing, literature screening, safety reporting, EU-QPPV consulting, and pharmacovigilance audits for marketing authorization holders. Charged on a service contract or per-project basis.
3. Dr. Notghi Academy Training: Certified GCP training courses for investigators, study nurses, and site staff. Revenue generated from course fees (e.g., Study Nurse Basic Course at EUR 1,199 + VAT, GCP refresher courses). Offered in-person and online (e-learning via ILIAS).
4. Clinical Data Transparency Services: Study data registration, plain language documentation, and publication services for sponsors to fulfill EU, US, and German transparency obligations. Billed as part of regulatory consulting engagements.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Dr. Notghi Contract Research is a Berlin-based full-service Contract Research Organization (CRO) that plans and manages clinical trials and non-interventional studies for pharmaceutical products and medical devices, delivers pharmacovigilance and drug-safety case processing, performs clinical evaluations and post-market surveillance for medical devices under MDR, handles study-data transparency and regulatory publishing, and runs the Dr. Notghi Academy providing certified GCP and study nurse training for sponsors and site staff across the D-A-CH region.

Product overview

Dr. Notghi Contract Research is a Full-Service Contract Research Organization (CRO) offering an integrated portfolio of clinical research, pharmacovigilance, and training services. The core offerings include Klinische Studien & Prüfungen (Clinical Studies) with sub-modules for project management, monitoring, data management, drug safety, medical writing, and consulting; Pharmakovigilanz with case processing, literature screening, safety reports, consulting, training, and audits; and Transparenz (Clinical Trial Transparency) for data publication and lay documentation. The company also provides Klinische Bewertungen (Clinical Evaluations) for medical devices and in-vitro diagnostics under MDR, and operates the Dr. Notghi Academy as a training sub-brand offering GCP courses and study nurse training. Services are delivered by an interdisciplinary team of scientists and physicians from their Berlin headquarters, with monitoring capabilities extended through partnership with Schantl Pharma Service GmbH.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over 100 PV audits conducted in the past 6 years across Europe and CIS states

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered core, supporting and minor.

• Schantl Pharma Service GmbHcoreChannel Partner/ Reseller/ Distributor · 1 August 2025Strategic cooperation agreement signed August 2025 for clinical trial monitoring. Schantl contributes seven experienced clinical monitors with monitoring locations across Germany (NRW: Düsseldorf, Köln, Kalletal; Hessen: Griesheim; Baden-Württemberg: Kißlegg; Bayern: Nuremberg; Schleswig-Holstein: Quickborn). Dr. Notghi CRO provides pharmacovigilance and drug safety expertise and ICH-GCP training for site staff via the Dr. Notghi Academy.
• Adliance GmbHsupportingTechnology or Integration · 1 March 2021Co-development of the Akriva tool — an innovative social media pharmacovigilance monitoring solution. Adliance provides the Akriva technology platform; Dr. Notghi CRO develops customized Akriva concepts with clients, integrating the tool for real-time adverse event detection across digital channels.
• BVMA e.V. (Bundesverband Medizinischer Auftragsinstitute)supportingOthersBVMA e.V. is the German industry association for Contract Research Organisations (CROs), founded in July 1991. Dr. Notghi CRO joined as a member in May 2021 following a successful audit. The association represents approximately 47 national and international CRO companies.
• Deutsche Krebs Gesellschaft e.V. (DKG)minorOthersListed as a member organization of the Deutsche Krebs Gesellschaft (German Cancer Society). Nature of membership is organizational/partnership support.
• Deutsche Gesellschaft für Pharmazeutische MedizinminorOthersListed as a member of the German Society for Pharmaceutical Medicine. Nature of membership is organizational/partnership support.
• ConelisminorOthersListed as a member organization of Conelis. Nature of membership is organizational/partnership support.
• BUVEBA e.V.minorOthersListed as a member organization of BUVEBA e.V. (Berlin-Brandenburg life sciences network). Nature of membership is organizational/partnership support.
• Biotechnologieverbund berlin-brandenburg (bbb)minorOthersListed as a member of the Biotechnology Association Berlin-Brandenburg. Nature of membership is organizational/partnership support.
• Arbeitsgemeinschaft für Angewandte Humanpharmakologie e. V. (AGAH)minorOthersListed as a member of AGAH (Working Group for Applied Human Pharmacology). Nature of membership is organizational/partnership support.
• DGPharMed e.V.supportingOthersDr. Notghi CRO hosts/organizes DGPharMed Meet Up Berlin-Brandenburg events (e.g., 57th Meet Up in October 2025). Melanie Wurzel serves on the DGPharMed board as Meet-Up coordinator. Active professional society engagement.

Scale indicators6 records

Recent moves12 records

Expansion highlights6 records

Direct peers

• FGK Clinical Research GmbH: Munich-based mid-size German full-service CRO offering Phase I–IV clinical trial management, biostatistics, medical writing, and pharmacovigilance. Directly comparable in size, geography (Germany/DACH), and full-service CRO scope.
• Winicker Norimed GmbH: Erlangen-based German CRO providing clinical trial management, monitoring, biostatistics, data management, and medical writing for pharma and medical device sponsors. Closely matches Dr. Notghi's service mix and DACH-focused mid-size positioning.
• Clinipace Worldwide: Mid-size global CRO offering full-service clinical development, biostatistics, regulatory, and PV services. Comparable as a similarly tiered full-service CRO targeting small-to-mid sized pharma, biotech, and device sponsors.
• CRM Biometrics GmbH: Aachen-based German biometrics/biostatistics CRO offering CDISC-compliant data management, statistical programming, and clinical study reporting. Comparable as a German CRO with overlapping data management, SAS, and CDISC capabilities.
• Worldwide Clinical Trials: Mid-size global CRO providing Phase I–IV clinical trial services, bioanalytical lab, and post-approval services. Comparable as a mid-tier full-service alternative for sponsors not engaging global mega-CROs.
• medac GmbH: Hamburg-based specialty pharma company that also operates a CRO arm (medac Clinical Research) supporting clinical trials of its own and third-party products. Comparable as a Germany-based pharma-adjacent CRO with overlapping regulatory and PV expertise.

Broad incumbents

• Parexel International: Large global CRO offering full-service clinical development, regulatory consulting, and post-approval services. Competes in the same end markets as Dr. Notghi but with a global footprint and broader therapeutic-area coverage.
• ICON plc: Global top-5 CRO offering full-service Phase I–IV clinical development, labs, real-world evidence, and consulting across all major geographies. Broad incumbent that competes for the same pharma and device sponsor RFPs as Dr. Notghi but at global scale.
• IQVIA Holdings Inc. World's largest CRO/clinical services platform integrating R&D solutions, real-world evidence, and technology. Operates broadly in the same clinical trial and PV services space that Dr. Notghi serves, but at global scale with proprietary technology platforms.
• Charles River Laboratories: Global CRO and preclinical/research services provider with growing clinical and PV service offerings. Competes broadly in clinical trial and drug safety services, but at materially greater scale and with a larger preclinical/early-phase footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xxing.com/companies/dr.notghicontractresearch
• LinkedInlinkedin.com/company/dr-notghi-contract-research-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dr. Notghi Contract Research